Skip to main content

Advertisement

Log in

Is water vapor thermal therapy safe and feasible in elderly and frail men? The Italian experience

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

In recent years, water vapor thermal therapy (WVTT) has spread as minimally invasive technique in lower urinary tract symptoms due to benign prostatic hyperplasia treatment. Even if its safety and feasibility have been largely proved in young men, nobody has proved the same feasibility and safety in the elderly (men older than 75 years old). Our aim is to compare WVTT safety outcomes in men older than 75 with younger men.

Methods

We prospectively collected data on men who underwent water vapor thermal therapy from 2019. We compared data on operative time, number of injections, intra-operative and post-operative complications, reinterventions rate.

Results

We enrolled 426 patients; among these, 60 were older than 75 years old, 366 were younger. Our cohorts of patients had similar results in terms of intra-operative and post-operative complications. Operative time accounts about 11 min for both groups (p = 0.535), total number of injections was seven for young men and eight for elderly (p = 0.314). We found no intra-operative complications in elderly men group and only one in the younger group (p = 0.678), while five younger men underwent clot retention, and two elderly men experienced this complication (p = 0.239). Only one transfusion occurred in the elderly group. No differences between groups occurred in terms of length of stay, post-operative urinary retention and reintervention rate, while catheterization time was longer in the elderly men.

Conclusion

WVTT is a safe procedure in elderly patients with comparable intra-operative and post-operative complication rate in comparison with younger patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The raw data are available upon reasonable and motivated request.

References

  1. Ng M, Baradhi KM (2023) Benign prostatic hyperplasia. StatPearls. StatPearls Publishing, Treasure Island

    Google Scholar 

  2. Ornaghi PI, Porreca A, Sandri M et al (2022) Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases. Prostate Cancer Prostat Dis. https://doi.org/10.1038/s41391-022-00575-w3

    Article  Google Scholar 

  3. Cindolo L, Pirozzi L, Fanizza C et al (2015) Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol 68:418–425. https://doi.org/10.1016/j.eururo.2014.11.006

    Article  PubMed  Google Scholar 

  4. McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185:1793–1803. https://doi.org/10.1016/j.juro.2011.01.074

    Article  PubMed  Google Scholar 

  5. Manfredi C, Arcaniolo D, Spatafora P et al (2022) Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. https://doi.org/10.23736/S2724-6051.21.04530-4

    Article  PubMed  Google Scholar 

  6. Woo HH, Huang CP, Huang WJ et al (2022) The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Prostate Cancer Prostat Dis 25:576–582. https://doi.org/10.1038/s41391-022-00548-z6

    Article  CAS  Google Scholar 

  7. Kaplan SA, Pichardo M, Rijo E et al (2021) One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate Cancer Prostat Dis 24:1073–1079. https://doi.org/10.1038/s41391-021-00362-z

    Article  CAS  Google Scholar 

  8. Siena G, Cindolo L, Ferrari G et al (2021) Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol 39:3875–3880. https://doi.org/10.1007/s00345-021-03642-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Siena G, Tellini R, Cindolo L (2022) Can Rezum stand out as the most versatile and better performing minimally invasive treatment for the management of LUTS related to BPH? Minerva Urol Nephrol. https://doi.org/10.23736/S2724-6051.22.04861-3

    Article  PubMed  Google Scholar 

  10. Campobasso D, Siena G, Chiodini P et al (2023) Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostat Dis 26:410–414. https://doi.org/10.1038/s41391-022-00587-6

    Article  Google Scholar 

  11. Khan KT, Hemati K, Donovan AL (2019) Geriatric physiology and the frailty syndrome. Anesthesiol Clin 37:453–474. https://doi.org/10.1016/j.anclin.2019.04.006

    Article  PubMed  Google Scholar 

  12. Campobasso D, Morselli S, Greco F et al (2023) Efficacy and safety profile of GreenLight laser photoselective vaporization of the prostate in ≥ 75 years old patients: results from the Italian GreenLight Laser Study Group. Aging Clin Exp Res 35:877–885. https://doi.org/10.1007/s40520-023-02351-9

    Article  PubMed  Google Scholar 

  13. Cindolo L, Campobasso D, Ferrari G et al (2022) Expanding indications for Rezum procedure. Urol Video J 14:100154. https://doi.org/10.1016/j.urolvj.2022.100154

    Article  Google Scholar 

  14. Vuichoud C, Loughlin KR (2015) Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 22(Suppl 1):1–6

    PubMed  Google Scholar 

  15. Huang J, Chan C-K, Yee S et al (2023) Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis. Prostate Cancer Prostat Dis 26:421–428. https://doi.org/10.1038/s41391-022-00610-w

    Article  Google Scholar 

  16. Albisinni S, Aoun F, Roumeguère T et al (2017) New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review. Minerva Urol Nephrol. https://doi.org/10.23736/S0393-2249.16.02743-0

    Article  Google Scholar 

  17. McVary KT, Rogers T, Mahon J, Gupta NK (2018) Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med 15:1728–1738. https://doi.org/10.1016/j.jsxm.2018.10.006

    Article  PubMed  Google Scholar 

  18. Sahakyan Y, Erman A, Bhojani N et al (2023) Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study. Prostate Cancer Prostat Dis 26:113–118. https://doi.org/10.1038/s41391-022-00561-2

    Article  Google Scholar 

  19. Elterman D, Bhojani N, Vannabouathong C et al (2022) Rezūm therapy for ≥80- mL benign prostatic enlargement: a large, multicentre cohort study. BJU Int 130:522–527. https://doi.org/10.1111/bju.15753

    Article  CAS  PubMed  Google Scholar 

  20. Spinos T, Katafigiotis I, Leotsakos I, Grivas N, Zabaftis C, Ermidis D, Sfoungaristos S, Karavitakis M (2023) Rezūm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature. World J Urol 41(2):413–420. https://doi.org/10.1007/s00345-022-04258-y

    Article  CAS  PubMed  Google Scholar 

  21. Babar M, Labagnara K, Loloi J et al (2023) Risk factors and real-world short-term outcomes of a failed trial of void after rezum therapy in a multiethnic population. J Endourol 37:67–73. https://doi.org/10.1089/end.2022.0490

    Article  PubMed  Google Scholar 

  22. Tadrist A, Baboudjian M, Bah MB et al (2022) Water vapor thermal therapy for indwelling urinary catheter removal in frail patients. Int Urol Nephrol 55:249–253. https://doi.org/10.1007/s11255-022-03408-w

    Article  PubMed  Google Scholar 

  23. Cornu J-N, Ahyai S, Bachmann A et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017

    Article  PubMed  Google Scholar 

  24. Nishi T, Maeda T, Imatoh T, Babazono A (2018) Comparison of regional with general anesthesia on mortality and perioperative length of stay in older patients after hip fracture surgery. Int J Qual Health Care. https://doi.org/10.1093/intqhc/mzy233

    Article  Google Scholar 

  25. Siena G, Sessa F, Cindolo L (2023) Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate. Prostate Cancer Prostat Dis. https://doi.org/10.1038/s41391-023-00644-8

    Article  Google Scholar 

  26. Elterman DS, Zorn KC, Bhojani N, Chughtai B (2022) Efficacy and safety of methoxyflurane (Penthrox) for pain control during water vapor thermal therapy (Rezum) for benign prostatic enlargement. Can J Urol 29:11355–11360

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

AM: data collection, manuscript writing. SM: data analysis, manuscript writing. FF: data collection. DM: data collection. FV: data collection. ST: data collection. GF: project development. GS: project development, data collection. EC: data collection. RP: project development. FU: project development. Balsamo R: project development, data collection. RMS: project development, manuscript supervision. LC: project development, data analysis, manuscript supervision.

Corresponding author

Correspondence to Luca Cindolo.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests and no other conflict of interests to disclose.

Research involving human and animal participants

The research involves human participants but not animals.

Ethical approval

To proceed with the study, ethical appraisal was obtained for the current study (Ref AOC-0020489-2022). Data sharing between centers was conducted according to EU privacy regulations, with anonymized data to safeguard patients’ privacy.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minore, A., Morselli, S., Franzoso, F. et al. Is water vapor thermal therapy safe and feasible in elderly and frail men? The Italian experience. World J Urol 42, 60 (2024). https://doi.org/10.1007/s00345-023-04762-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00345-023-04762-9

Keywords

Navigation